Conduit Pharmaceuticals Inc. (CDT)
NASDAQ: CDT · IEX Real-Time Price · USD
2.990
-0.070 (-2.29%)
May 2, 2024, 4:00 PM EDT - Market closed
Conduit Pharmaceuticals Market Cap
Conduit Pharmaceuticals has a market cap or net worth of $220.75 million as of May 2, 2024. Its market cap has increased by 237.54% in one year.
Market Cap
220.75M
Enterprise Value
217.51M
1-Year Change
237.54%
Ranking
Category
Stock Price
$2.99
Market Cap Chart
Since February 3, 2022, Conduit Pharmaceuticals's market cap has increased from $151.10M to $220.75M, an increase of 46.10%. That is a compound annual growth rate of 18.41%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 2, 2024 | 220.80M | 6.05% |
May 1, 2024 | 208.20M | -6.30% |
Apr 30, 2024 | 222.20M | -9.89% |
Apr 29, 2024 | 246.60M | 5.38% |
Apr 26, 2024 | 234.00M | 2.23% |
Apr 25, 2024 | 228.90M | -2.51% |
Apr 24, 2024 | 234.80M | 0.95% |
Apr 23, 2024 | 232.60M | 2.29% |
Apr 22, 2024 | 227.40M | -1.26% |
Apr 19, 2024 | 230.30M | 4.30% |
Apr 18, 2024 | 220.80M | 0.68% |
Apr 17, 2024 | 219.30M | -3.86% |
Apr 16, 2024 | 228.10M | -4.04% |
Apr 15, 2024 | 237.70M | 1.24% |
Apr 12, 2024 | 234.80M | -0.30% |
Apr 11, 2024 | 235.50M | 2.88% |
Apr 10, 2024 | 228.90M | -2.18% |
Apr 9, 2024 | 234.00M | -2.46% |
Apr 8, 2024 | 239.90M | -0.33% |
Apr 5, 2024 | 240.70M | -0.29% |
Apr 4, 2024 | 241.40M | -2.11% |
Apr 3, 2024 | 246.60M | -2.61% |
Apr 2, 2024 | 253.20M | -2.28% |
Apr 1, 2024 | 259.10M | -4.39% |
Mar 28, 2024 | 271.00M | 2.81% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Accuray | 215.20M |
Lineage Cell Therapeutics | 213.04M |
Renovaro Biosciences | 211.19M |
Auna S.A. | 210.00M |
Eliem Therapeutics | 209.84M |
Innate Pharma | 205.34M |
Adverum Biotechnologies | 203.19M |
Design Therapeutics | 202.73M |